DDR2 expression is associated with a high frequency of peritoneal dissemination and poor prognosis in colorectal cancer

Shin Sasaki, Masami Ueda, Tomohiro Iguchi, Manabu Kaneko, Hiroshi Nakayama, Toshiyuki Watanabe, Atsuhiko Sakamoto, Koshi Mimori

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: We previously identified discoidindomain receptor 2 (DDR2) as a promising driver gene of peritoneal dissemination (PD) in gastric cancer. In the present study we explored the clinical significance of DDR2 expression in colorectal cancer (CRC). Materials and Methods: We examined DDR2 expression in CRC specimens by immunohistochemistry. We analyzed the association of DDR2 expression with clinicopathological factors in CRC. We divided 63 CRC cases into two groups according to their level of DDR2 expression and compared several clinicopathological factors and their overall survival. Results: The group with high DDR2 expression had significantly higher frequencies of T4, lymph node metastasis, and PD compared to the group with low DDR2 expression. Furthermore, the prognosis of the group with high DDR2 expression was significantly poorer than the group with low DDR2. Conclusion: DDR2 is a powerful biomarker that can predict poor prognosis as well as PD, and might be an effective therapeutic target for CRC.

Original languageEnglish
Pages (from-to)2587-2591
Number of pages5
JournalAnticancer research
Volume37
Issue number5
DOIs
Publication statusPublished - May 1 2017

Fingerprint

Colorectal Neoplasms
Stomach Neoplasms
Biomarkers
Lymph Nodes
Immunohistochemistry
Neoplasm Metastasis
Genes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

DDR2 expression is associated with a high frequency of peritoneal dissemination and poor prognosis in colorectal cancer. / Sasaki, Shin; Ueda, Masami; Iguchi, Tomohiro; Kaneko, Manabu; Nakayama, Hiroshi; Watanabe, Toshiyuki; Sakamoto, Atsuhiko; Mimori, Koshi.

In: Anticancer research, Vol. 37, No. 5, 01.05.2017, p. 2587-2591.

Research output: Contribution to journalArticle

Sasaki, Shin ; Ueda, Masami ; Iguchi, Tomohiro ; Kaneko, Manabu ; Nakayama, Hiroshi ; Watanabe, Toshiyuki ; Sakamoto, Atsuhiko ; Mimori, Koshi. / DDR2 expression is associated with a high frequency of peritoneal dissemination and poor prognosis in colorectal cancer. In: Anticancer research. 2017 ; Vol. 37, No. 5. pp. 2587-2591.
@article{248707dd49424afc8aa10d5b731d596e,
title = "DDR2 expression is associated with a high frequency of peritoneal dissemination and poor prognosis in colorectal cancer",
abstract = "Background: We previously identified discoidindomain receptor 2 (DDR2) as a promising driver gene of peritoneal dissemination (PD) in gastric cancer. In the present study we explored the clinical significance of DDR2 expression in colorectal cancer (CRC). Materials and Methods: We examined DDR2 expression in CRC specimens by immunohistochemistry. We analyzed the association of DDR2 expression with clinicopathological factors in CRC. We divided 63 CRC cases into two groups according to their level of DDR2 expression and compared several clinicopathological factors and their overall survival. Results: The group with high DDR2 expression had significantly higher frequencies of T4, lymph node metastasis, and PD compared to the group with low DDR2 expression. Furthermore, the prognosis of the group with high DDR2 expression was significantly poorer than the group with low DDR2. Conclusion: DDR2 is a powerful biomarker that can predict poor prognosis as well as PD, and might be an effective therapeutic target for CRC.",
author = "Shin Sasaki and Masami Ueda and Tomohiro Iguchi and Manabu Kaneko and Hiroshi Nakayama and Toshiyuki Watanabe and Atsuhiko Sakamoto and Koshi Mimori",
year = "2017",
month = "5",
day = "1",
doi = "10.21873/anticanres.11603",
language = "English",
volume = "37",
pages = "2587--2591",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - DDR2 expression is associated with a high frequency of peritoneal dissemination and poor prognosis in colorectal cancer

AU - Sasaki, Shin

AU - Ueda, Masami

AU - Iguchi, Tomohiro

AU - Kaneko, Manabu

AU - Nakayama, Hiroshi

AU - Watanabe, Toshiyuki

AU - Sakamoto, Atsuhiko

AU - Mimori, Koshi

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Background: We previously identified discoidindomain receptor 2 (DDR2) as a promising driver gene of peritoneal dissemination (PD) in gastric cancer. In the present study we explored the clinical significance of DDR2 expression in colorectal cancer (CRC). Materials and Methods: We examined DDR2 expression in CRC specimens by immunohistochemistry. We analyzed the association of DDR2 expression with clinicopathological factors in CRC. We divided 63 CRC cases into two groups according to their level of DDR2 expression and compared several clinicopathological factors and their overall survival. Results: The group with high DDR2 expression had significantly higher frequencies of T4, lymph node metastasis, and PD compared to the group with low DDR2 expression. Furthermore, the prognosis of the group with high DDR2 expression was significantly poorer than the group with low DDR2. Conclusion: DDR2 is a powerful biomarker that can predict poor prognosis as well as PD, and might be an effective therapeutic target for CRC.

AB - Background: We previously identified discoidindomain receptor 2 (DDR2) as a promising driver gene of peritoneal dissemination (PD) in gastric cancer. In the present study we explored the clinical significance of DDR2 expression in colorectal cancer (CRC). Materials and Methods: We examined DDR2 expression in CRC specimens by immunohistochemistry. We analyzed the association of DDR2 expression with clinicopathological factors in CRC. We divided 63 CRC cases into two groups according to their level of DDR2 expression and compared several clinicopathological factors and their overall survival. Results: The group with high DDR2 expression had significantly higher frequencies of T4, lymph node metastasis, and PD compared to the group with low DDR2 expression. Furthermore, the prognosis of the group with high DDR2 expression was significantly poorer than the group with low DDR2. Conclusion: DDR2 is a powerful biomarker that can predict poor prognosis as well as PD, and might be an effective therapeutic target for CRC.

UR - http://www.scopus.com/inward/record.url?scp=85019054973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019054973&partnerID=8YFLogxK

U2 - 10.21873/anticanres.11603

DO - 10.21873/anticanres.11603

M3 - Article

VL - 37

SP - 2587

EP - 2591

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5

ER -